DR Congo Ebola vaccine trial to begin within weeks: WHO

The first clinical trial of an Ebola vaccine is set to begin in the Democratic Republic of Congo by the end of October, according to World Health Organization experts.

This trial is a significant step in the global fight against Ebola, which has caused numerous outbreaks in the past, including a recent one in West Africa that resulted in thousands of deaths.

The vaccine, developed by Merck, has shown promising results in previous trials and could potentially save many lives if proven effective.